Lavanya Saiva

  • Citations Per Year
Learn More
Case report Fingolimod (sphingosine-1-phosphate receptor (S1PR) mod-ulator; FTY720) has been recently identified as a novel therapeutic agent in multiple sclerosis. However, several reports in current literature raise concerns regarding rare cases of cardiac complications as a consequence of the medication [1–3]. A 24-year-old lady was electively admitted(More)
  • 1